Born on climate-vulnerable Miami Beach and amplified at Climate Week NYC, Our Present, Icarus' Future uses immersive ...

Furthermore, the Company has received additional total gross proceeds of C$42,126.72 from the early exercise of 113,856 class A shares purchase warrants (the " Warrants ") at a price of $0.37 per ...

HIROSHIMA, Japan, Nov 17, 2025 - (JCN Newswire) - Mazda Motor Corporation today announced that it has begun demonstration ...

桑尼維爾, 2025年11月17日 - (亞太商訊) - Graid Technology 今日宣佈，已成功完成與英特爾公司（Intel Corporation）的協議，取得行銷、銷售及開發 Intel® Virtual RAID on ...

Toyota City, Japan, Nov 17, 2025 - (JCN Newswire) - Toyota Motor Corporation (Toyota) will further advance two hydrogen ...

Building on its achievements in the food distribution industry, Fujitsu plans to expand the lab's initiatives to other ...

胆管癌は希少かつ致死率の高い悪性腫瘍であり、米国内の患者数は5万人未満、5年生存率は疾患ステージ、組織型、病変部位により2〜23％とされています¹。現在、胆管癌に対するFDA承認のADC治療薬は存在していません。

This technology will be showcased at the NTT R&D FORUM 2025, hosted by NTT from November 19–21 and November 25–26, 2025. Further details on the official event website: https://www.rd.ntt/e/forum/2025/ ...

"This agreement represents an exciting new chapter for Graid Technology and for the global ecosystem that relies on Intel® ...

尽管零售环境仍具挑战，集团于报告期内录得稳健增长，收益上升7.7%至4.3亿港元，股东应占溢利上升20.0%至1.15亿港元。业绩表现主要受惠于旗下旗舰自主品牌的持续动力、多元化产品组合以及严谨的执行力。集团继续透过综合市场推广、电子商贸拓展及策略性互动合作，进一步强化品牌资产并扩展于香港及大湾区的市场覆盖。

Limited (“JBM Healthcare” or the “Company”, Stock Code: 2161, together with its subsidiaries, the “Group”), a leading branded healthcare products marketer and distributor in Hong Kong, today announced ...

TOKYO, Nov 17, 2025 - (JCN Newswire) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that its ...